Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice

Balaji Balasa, Jae Lee, Nora E Sarvetnick

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Expression of IL-10 transgene (tg) in pancreatic β cells failed to induce autoimmune insulitis and diabetes in (BALB/c x NOD)F1 mice. However, IL-10-expressing tg littermates from backcrosses (N2 and N3) with NOD mice became diabetic at 5 to 10 weeks of age in an MHC-dependent manner. In this study, we tested the possibility that enhancement in frequency of islet antigen (Ag)-specific T cells overrides the protective effects of a diabetes- resistant genetic background and promotes diabetes in IL-10 tg (BALB/c x NOD)F1 mice. For this test, we introduced the IL-10 transgene into tg BDC2.5 mice expressing the islet Ag-specific Vβ4 T cell repertoire by breeding Ins- IL-10+/BALB/c mice with BDC2.5 mice. The progeny (Ins-IL-10+/BALB/c x BDC2.5+)F1 mice doubly tg for IL-10 and Vβ4 (BDC2.5) T cell repertoire, developed diabetes at 10 to 18 weeks of age with a much more aggressive T cell infiltrate in the pancreatic islets than in single tg mice. Surprisingly, these diabetic mice were free from acute pancreatitis but had apoptotic β cells in the islet infiltrate. Conversely, mice tg for Vβ4 (BDC2.5) T cell repertoire but not IL-10 had no diabetes and no apoptotic β cells in the islet infiltrate. Therefore, an increase in the frequency of islet-specific T cells apparently overcomes the protection from diabetes by a resistant genetic background. Interestingly, N2 backcross mice doubly tg for Vβ4 (BDC2.5) T cell repertoire and IL-10, compared to N2 backcross mice tg for IL-10 only, eventually became diabetic but with a delayed onset and reduced incidence of disease. These findings demonstrate that, along with IL- 10, an increase in frequency of islet antigen-specific T cells (a) overrides the protective effect of genetic resistance to autoimmune diabetes in F1 mice and (b) delays the onset of an otherwise accelerated diabetes in (Ins-IL- 10+/NOD)N2 backcross mice.

Original languageEnglish (US)
Pages (from-to)170-178
Number of pages9
JournalCellular Immunology
Volume193
Issue number2
DOIs
StatePublished - May 1 1999

Fingerprint

Interleukin-10
Transgenic Mice
T-Lymphocytes
Transgenes
Inbred NOD Mouse
Type 1 Diabetes Mellitus
Antigens

ASJC Scopus subject areas

  • Immunology

Cite this

Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice. / Balasa, Balaji; Lee, Jae; Sarvetnick, Nora E.

In: Cellular Immunology, Vol. 193, No. 2, 01.05.1999, p. 170-178.

Research output: Contribution to journalArticle

@article{7dd2a1e72d2a4863a5cb600f73754392,
title = "Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice",
abstract = "Expression of IL-10 transgene (tg) in pancreatic β cells failed to induce autoimmune insulitis and diabetes in (BALB/c x NOD)F1 mice. However, IL-10-expressing tg littermates from backcrosses (N2 and N3) with NOD mice became diabetic at 5 to 10 weeks of age in an MHC-dependent manner. In this study, we tested the possibility that enhancement in frequency of islet antigen (Ag)-specific T cells overrides the protective effects of a diabetes- resistant genetic background and promotes diabetes in IL-10 tg (BALB/c x NOD)F1 mice. For this test, we introduced the IL-10 transgene into tg BDC2.5 mice expressing the islet Ag-specific Vβ4 T cell repertoire by breeding Ins- IL-10+/BALB/c mice with BDC2.5 mice. The progeny (Ins-IL-10+/BALB/c x BDC2.5+)F1 mice doubly tg for IL-10 and Vβ4 (BDC2.5) T cell repertoire, developed diabetes at 10 to 18 weeks of age with a much more aggressive T cell infiltrate in the pancreatic islets than in single tg mice. Surprisingly, these diabetic mice were free from acute pancreatitis but had apoptotic β cells in the islet infiltrate. Conversely, mice tg for Vβ4 (BDC2.5) T cell repertoire but not IL-10 had no diabetes and no apoptotic β cells in the islet infiltrate. Therefore, an increase in the frequency of islet-specific T cells apparently overcomes the protection from diabetes by a resistant genetic background. Interestingly, N2 backcross mice doubly tg for Vβ4 (BDC2.5) T cell repertoire and IL-10, compared to N2 backcross mice tg for IL-10 only, eventually became diabetic but with a delayed onset and reduced incidence of disease. These findings demonstrate that, along with IL- 10, an increase in frequency of islet antigen-specific T cells (a) overrides the protective effect of genetic resistance to autoimmune diabetes in F1 mice and (b) delays the onset of an otherwise accelerated diabetes in (Ins-IL- 10+/NOD)N2 backcross mice.",
author = "Balaji Balasa and Jae Lee and Sarvetnick, {Nora E}",
year = "1999",
month = "5",
day = "1",
doi = "10.1006/cimm.1999.1484",
language = "English (US)",
volume = "193",
pages = "170--178",
journal = "Cellular Immunology",
issn = "0008-8749",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice

AU - Balasa, Balaji

AU - Lee, Jae

AU - Sarvetnick, Nora E

PY - 1999/5/1

Y1 - 1999/5/1

N2 - Expression of IL-10 transgene (tg) in pancreatic β cells failed to induce autoimmune insulitis and diabetes in (BALB/c x NOD)F1 mice. However, IL-10-expressing tg littermates from backcrosses (N2 and N3) with NOD mice became diabetic at 5 to 10 weeks of age in an MHC-dependent manner. In this study, we tested the possibility that enhancement in frequency of islet antigen (Ag)-specific T cells overrides the protective effects of a diabetes- resistant genetic background and promotes diabetes in IL-10 tg (BALB/c x NOD)F1 mice. For this test, we introduced the IL-10 transgene into tg BDC2.5 mice expressing the islet Ag-specific Vβ4 T cell repertoire by breeding Ins- IL-10+/BALB/c mice with BDC2.5 mice. The progeny (Ins-IL-10+/BALB/c x BDC2.5+)F1 mice doubly tg for IL-10 and Vβ4 (BDC2.5) T cell repertoire, developed diabetes at 10 to 18 weeks of age with a much more aggressive T cell infiltrate in the pancreatic islets than in single tg mice. Surprisingly, these diabetic mice were free from acute pancreatitis but had apoptotic β cells in the islet infiltrate. Conversely, mice tg for Vβ4 (BDC2.5) T cell repertoire but not IL-10 had no diabetes and no apoptotic β cells in the islet infiltrate. Therefore, an increase in the frequency of islet-specific T cells apparently overcomes the protection from diabetes by a resistant genetic background. Interestingly, N2 backcross mice doubly tg for Vβ4 (BDC2.5) T cell repertoire and IL-10, compared to N2 backcross mice tg for IL-10 only, eventually became diabetic but with a delayed onset and reduced incidence of disease. These findings demonstrate that, along with IL- 10, an increase in frequency of islet antigen-specific T cells (a) overrides the protective effect of genetic resistance to autoimmune diabetes in F1 mice and (b) delays the onset of an otherwise accelerated diabetes in (Ins-IL- 10+/NOD)N2 backcross mice.

AB - Expression of IL-10 transgene (tg) in pancreatic β cells failed to induce autoimmune insulitis and diabetes in (BALB/c x NOD)F1 mice. However, IL-10-expressing tg littermates from backcrosses (N2 and N3) with NOD mice became diabetic at 5 to 10 weeks of age in an MHC-dependent manner. In this study, we tested the possibility that enhancement in frequency of islet antigen (Ag)-specific T cells overrides the protective effects of a diabetes- resistant genetic background and promotes diabetes in IL-10 tg (BALB/c x NOD)F1 mice. For this test, we introduced the IL-10 transgene into tg BDC2.5 mice expressing the islet Ag-specific Vβ4 T cell repertoire by breeding Ins- IL-10+/BALB/c mice with BDC2.5 mice. The progeny (Ins-IL-10+/BALB/c x BDC2.5+)F1 mice doubly tg for IL-10 and Vβ4 (BDC2.5) T cell repertoire, developed diabetes at 10 to 18 weeks of age with a much more aggressive T cell infiltrate in the pancreatic islets than in single tg mice. Surprisingly, these diabetic mice were free from acute pancreatitis but had apoptotic β cells in the islet infiltrate. Conversely, mice tg for Vβ4 (BDC2.5) T cell repertoire but not IL-10 had no diabetes and no apoptotic β cells in the islet infiltrate. Therefore, an increase in the frequency of islet-specific T cells apparently overcomes the protection from diabetes by a resistant genetic background. Interestingly, N2 backcross mice doubly tg for Vβ4 (BDC2.5) T cell repertoire and IL-10, compared to N2 backcross mice tg for IL-10 only, eventually became diabetic but with a delayed onset and reduced incidence of disease. These findings demonstrate that, along with IL- 10, an increase in frequency of islet antigen-specific T cells (a) overrides the protective effect of genetic resistance to autoimmune diabetes in F1 mice and (b) delays the onset of an otherwise accelerated diabetes in (Ins-IL- 10+/NOD)N2 backcross mice.

UR - http://www.scopus.com/inward/record.url?scp=0032942742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032942742&partnerID=8YFLogxK

U2 - 10.1006/cimm.1999.1484

DO - 10.1006/cimm.1999.1484

M3 - Article

VL - 193

SP - 170

EP - 178

JO - Cellular Immunology

JF - Cellular Immunology

SN - 0008-8749

IS - 2

ER -